Brief: Innovative Pharmaceutical Biotech Posts HY Loss Attributable HK$110.5 MLN
29/11/2019 15:19
Nov 29 (Reuters) - Innovative Pharmaceutical Biotech Ltd
0399.HK :
* HY LOSS ATTRIBUTABLE HK$110.5 MILLION VERSUS LOSS OF
HK$171.3
MILLION
Source text for Eikon: ID:nHKS9pg5D6
Further company coverage: 0399.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU